ACTION:
Notice of registration.
SUMMARY:
Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION:
The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.
| Company | FR docket | Published |
|---|---|---|
| Noramco Inc | 83 FR 53107 | October 19, 2018. |
| Catalent CTS, LLC | 83 FR 54613 | October 30, 2018. |
| United States Pharmacopeial Convention | 83 FR 54611 | October 30, 2018. |
| Fisher Clinical Services, Inc | 83 FR 54612 | October 30, 2018. |
| Cambrex High Point, Inc | 83 FR 54610 | October 30, 2018. |
| Sharp (Bethlehem), LLC | 83 FR 54612 | October 30, 2018. |
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each of the company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed companies.
Dated: December 21, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-01519 Filed 2-6-19; 8:45 am]
BILLING CODE 4410-09-P